Successful early rituximab treatment in a case of systemic lupus erythematosus with potentially fatal diffuse alveolar hemorrhage

Respiration

Volumn 89, Issue 1, 2014, Pages 62-65

  Na, Ju Ock ^a   Chang, Sung Hae ^a   Seo, Ki Hyeon ^a   Choi, Jae Sung ^a   Lee, Ho Sung ^a   Lyu, Ji Won ^a   Nah, Seoung Su ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Diffuse alveolar hemorrhage; Rituximab; Systemic lupus erythematosus

Indexed keywords

ANTIBIOTIC AGENT; METHYLPREDNISOLONE; PREDNISOLONE; RITUXIMAB; IMMUNOLOGIC FACTOR;

ACUTE RESPIRATORY FAILURE; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; FEMALE; HUMAN; LUNG HEMORRHAGE; LUNG INFILTRATE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; COMPLICATION; HEMORRHAGE; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC;

ADULT; FEMALE; HEMORRHAGE; HUMANS; IMMUNOLOGIC FACTORS; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; RITUXIMAB;

EID: 84928206594     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000369038     Document Type: Article

References (15)

1. Kwok SK, Moon SJ, Ju JH, et al: Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea. Lupus 2011; 20: 102-107.
2. Braun-Moscovici Y, Butbul-Aviel Y, Gualnik L, et al: Rituximab: rescue therapy in lifethreatening complications or refractory autoimmune diseases: a single center experience. Rheumatol Int 2013; 33: 1495-1504.
3. Pego-Reigosa JM, Medeiros DA, Isenberg DA: Respiratory manifestations of systemic lupus erythematosus: old and new concepts. Best Pract Res Clin Rheumatol 2009; 23: 469-480.
4. Badsha H, Teh CL, Kong KO, Lian TY, Chng HH: Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 2004; 33: 414-421.
5. Kamen DL, Strange C: Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med 2010; 31: 479-488.
6. Narshi CB, Haider S, Ford CM, Isenberg DA, Giles IP: Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus. Rheumatology (Oxford) 2009; 49: 392-394.
7. Smith KG, Jones RB, Burns SM, Jayne DR: Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment. Arthritis Rheum 2006; 54: 2970-2982.
8. Lee JW, Kim HA, Sung JM, Suh CH: Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus. Lupus 2009; 19: 227-228.
9. Nellessen CM, Poge U, Brensing KA, Sauerbruch T, Klehr HU, Rabe C: Diffuse alveolar haemorrhage in a systemic lupus erythematosus patient successfully treated with rituximab: a case report. Nephrol Dial Transplant 2008; 23: 385-386.
10. Pottier V, Pierrot M, Subra JF, et al: Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage. Lupus 2011; 20: 656-659.
11. Todd DJ, Costenbader KH: Dyspnoea in a young woman with active systemic lupus erythematosus. Lupus 2009; 18: 777-784.
12. Martinez-Martinez MU, Abud-Mendoza C: Recurrent diffuse alveolar haemorrhage in a patient with systemic lupus erythematosus: long-term benefit of rituximab. Lupus 2012; 21: 1124-1127.
13. Pinto LF, Candia L, Gagcia P, et al: Effective treatment of refractory pulmonary hemorrhage with monoclonal anti-CD20 antibody (rituximab). Respiration 2009; 78: 106-109.
14. Rojas-Serrano J, Pedroza J, Regalado J, et al: High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage. Lupus 2008; 17: 295-299.
15. McFarland HF: The B cell -old player, new position on the team. N Engl J Med 2008; 358: 664-665.